099750 — ezCareTech Co Balance Sheet
0.000.00%
- KR₩120bn
- KR₩111bn
- KR₩68bn
- 69
- 34
- 89
- 73
Annual balance sheet for ezCareTech Co, fiscal year end - March 31st, KRW millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8,515 | 14,623 | 7,996 | 10,773 | 10,284 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 22,972 | 14,375 | 22,232 | 24,095 | 16,161 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 32,808 | 29,924 | 30,977 | 36,052 | 27,662 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,688 | 3,489 | 3,867 | 2,868 | 2,704 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 58,411 | 52,887 | 55,413 | 59,264 | 46,806 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,905 | 11,829 | 20,509 | 21,893 | 9,251 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 16,902 | 19,006 | 23,774 | 25,103 | 12,046 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 41,509 | 33,881 | 31,639 | 34,161 | 34,760 |
Total Liabilities & Shareholders' Equity | 58,411 | 52,887 | 55,413 | 59,264 | 46,806 |
Total Common Shares Outstanding |